Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michele H Potashman

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
BMJ Open|April 1, 2018
Measuring quality of life of people with predementia and dementia and their caregivers: a systematic review protocolFilipa Landeiro, Katie Walsh, Isaac Ghinai, et al.
Epilepsy & Behavior : E&B|September 5, 2025
Understanding lived experiences with KCNQ2 developmental and epileptic encephalopathyMichele H Potashman, Katja Rudell, Linda Abetz-Webb, et al.
Neurology and Therapy|February 18, 2026
Incorporating Patient Perspectives into a Composite Score for Measuring Disease Progression in Spinocerebellar Ataxia (SCA)Michele H Potashman, Basia M Rogula, Lauren C Powell, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|March 26, 2019
What outcomes are important to patients with mild cognitive impairment or Alzheimer's disease, their caregivers, and health-care professionals? A systematic reviewClaire Tochel, Michael Smith, Helen Baldwin, et al.
Alzheimer'S Research & Therapy|November 19, 2020
Health-related quality of life in people with predementia Alzheimer's disease, mild cognitive impairment or dementia measured with preference-based instruments: a systematic literature reviewFilipa Landeiro, Seher Mughal, Katie Walsh, et al.
Journal of Alzheimer'S Disease : JAD|December 26, 2018
Challenges for Optimizing Real-World Evidence in Alzheimer's Disease: The ROADMAP ProjectJohn Gallacher, Frederic de Reydet de Vulpillieres, Billy Amzal, et al.
Bioorganic & Medicinal Chemistry Letters|October 13, 2009
Discovery and optimization of potent and selective triazolopyridazine series of c-Met inhibitorsAlessandro A Boezio, Loren Berry, Brian K Albrecht, et al.
Journal of Medicinal Chemistry|August 19, 2007
Design, synthesis, and evaluation of orally active benzimidazoles and benzoxazoles as vascular endothelial growth factor-2 receptor tyrosine kinase inhibitorsMichele H Potashman, James Bready, Angela Coxon, et al.
Bioorganic & Medicinal Chemistry Letters|July 7, 2012
Discovery and optimization of potent and selective imidazopyridine and imidazopyridazine mTOR inhibitorsEmily A Peterson, Alessandro A Boezio, Paul S Andrews, et al.
Journal of Medicinal Chemistry|April 23, 2008
Discovery and optimization of triazolopyridazines as potent and selective inhibitors of the c-Met kinaseBrian K Albrecht, Jean-Christophe Harmange, David Bauer, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
BMJ Open|April 1, 2018
Measuring quality of life of people with predementia and dementia and their caregivers: a systematic review protocolFilipa Landeiro, Katie Walsh, Isaac Ghinai, et al.
Epilepsy & Behavior : E&B|September 5, 2025
Understanding lived experiences with KCNQ2 developmental and epileptic encephalopathyMichele H Potashman, Katja Rudell, Linda Abetz-Webb, et al.
Neurology and Therapy|February 18, 2026
Incorporating Patient Perspectives into a Composite Score for Measuring Disease Progression in Spinocerebellar Ataxia (SCA)Michele H Potashman, Basia M Rogula, Lauren C Powell, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|March 26, 2019
What outcomes are important to patients with mild cognitive impairment or Alzheimer's disease, their caregivers, and health-care professionals? A systematic reviewClaire Tochel, Michael Smith, Helen Baldwin, et al.
Alzheimer'S Research & Therapy|November 19, 2020
Health-related quality of life in people with predementia Alzheimer's disease, mild cognitive impairment or dementia measured with preference-based instruments: a systematic literature reviewFilipa Landeiro, Seher Mughal, Katie Walsh, et al.
Journal of Alzheimer'S Disease : JAD|December 26, 2018
Challenges for Optimizing Real-World Evidence in Alzheimer's Disease: The ROADMAP ProjectJohn Gallacher, Frederic de Reydet de Vulpillieres, Billy Amzal, et al.
Bioorganic & Medicinal Chemistry Letters|October 13, 2009
Discovery and optimization of potent and selective triazolopyridazine series of c-Met inhibitorsAlessandro A Boezio, Loren Berry, Brian K Albrecht, et al.
Journal of Medicinal Chemistry|August 19, 2007
Design, synthesis, and evaluation of orally active benzimidazoles and benzoxazoles as vascular endothelial growth factor-2 receptor tyrosine kinase inhibitorsMichele H Potashman, James Bready, Angela Coxon, et al.
Bioorganic & Medicinal Chemistry Letters|July 7, 2012
Discovery and optimization of potent and selective imidazopyridine and imidazopyridazine mTOR inhibitorsEmily A Peterson, Alessandro A Boezio, Paul S Andrews, et al.
Journal of Medicinal Chemistry|April 23, 2008
Discovery and optimization of triazolopyridazines as potent and selective inhibitors of the c-Met kinaseBrian K Albrecht, Jean-Christophe Harmange, David Bauer, et al.
Pageof 2